1. 1) Yamawaki S., “Pathogenesis, Diagnosis and Therapy of Neuroleptic Malignant Syndrome,” Shinkoh Igaku Shuppansha Co., Ltd., Tokyo, 1989, pp. 56-65.
2. 2) UpToDate. Neuroleptic malignant syndrome: 〈http://www.uptodate.com/contents/topic.do?topicKey=NEURO/4829〉, cited 3 September, 2015.
3. 3) Ministry of Health, Labour and Welfare, “Manual for handling disorders due to adverse drug reactions, malignant syndrome,” 2008, pp. 1-26.
4. 4) Keck P. E. Jr., Pope H. G. Jr., Cohen B. M., McElroy S. L., Nierenberg A. A., Arch. Gen. Psychiatry, 46, 914-918 (1989).
5. 5) Britt B. A., Can. Anaesth. Soc. J., 32, S40-S41 (1985).